Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.335 USD | +4.87% | +4.53% | +20.76% |
May. 14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.76% | 114M | |
+31.37% | 588B | |
-2.78% | 364B | |
+20.37% | 326B | |
+5.51% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.22% | 167B | |
0.00% | 161B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Cellectar Biosciences, Florida Cancer Specialists & Research Institute to Collaborate on Lymphoma Research